The Lexus ES has always been a rational luxury car. Since its 1989 debut, it has served buyers who wanted the refinement, quietness, reliability, and dealership experience of a premium brand without ...

“The more things change, the more they stay the same.” This well-known aphorism, taken from the original French (“Plus ça change…”) could be well applied to the eighth-generation Lexus ES. Sure, there ...

For the first time, the ES hybrid is available with an all-wheel-drive option. Lexus says the hybrid version of the eighth-generation ES is on track for its expected June arrival, when it will join ...

Git isn't hard to learn, and when you combine Git and GitHub, you've just made the learning process significantly easier. This two-hour Git and GitHub video tutorial shows you how to get started with ...

Lexus introduces the all-electric front-drive ES 350e and all-wheel-drive 500e. A hybrid ES is coming soon. The ES 350e has a 307-mile EPA-estimated total driving range, Lexus says. Pricing starts at ...

A new test firmware build from Blackmagic Design extends phase-detection autofocus to the PYXIS 6K, following its introduction on the Cinema Camera 6K last year. The latest beta version of Blackmagic ...

View post: Tesla Model Y L Is Now America’s Priciest Model Y—Offers More Than Just Captain’s Seats The 2026 Lexus ES starts under $50,000, undercutting rival luxury sedans in price. The entry-level EV ...

Pyxis Tankers Inc. operates as a maritime transportation company with a focus on the tanker and dry-bulk sectors in the United States and internationally. It operates through two segments: Tanker ...

Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat solid tumors. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an ...

Pyxis secured S$13 million in the first close of its S$18 million growth funding round, reflecting strong investor confidence in its vessel technology, commercial traction, and regional growth ...

BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that ...